Safe Pro Group Inc.
SPAIAnalytical Summary
Safe Pro Group Inc. demonstrates solid fundamentals with strength in Debt to Equity. Consider comparing against peers in the Healthcare sector before making investment decisions.
4-Year Financial Trajectory
AnnualBullish Indicators
- Debt to EquityDebt to Equity is in the top quartile (lower is better)
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Revenue Growth YoY (%) |
-72.0%
Weak
Weak
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Below avg (-1000%)
|
136.4%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+1605%)
|
— | — |
| EPS Growth YoY (%) |
-21.4%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
11.4%
Fair
Fair
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — |
| Net Income Growth YoY (%) |
-92.8%
Weak
Weak
Year-over-year change in net income |
-17.6%
Weak
Weak
Year-over-year change in net income |
— | — |
| FCF Growth YoY (%) |
5.4%
Fair
Fair
Year-over-year change in free cash flow |
-53.8%
Weak
Weak
Year-over-year change in free cash flow |
— | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Operating Margin (%) (%) | — |
-329.7%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-2298%)
|
— | — |
| Profit Margin (%) (%) | — |
-342.5%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-2954%)
|
— | — |
| FCF Margin (%) (%) | — |
-191.7%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-221.6%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
| FCF / Net Income (x) |
0.44x
Weak
→
Weak
Stable
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.56x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.32x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Return on Invested Capital (%) |
-64.3%
Weak
↑
Weak
Improving
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-140.5%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-280.5%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
| Return on Capital (%) (%) |
-76.1%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-144.5%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-183.9%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— |
| Return on Common Equity (%) (%) |
-80.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-639%)
|
-191.7%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-1378%)
|
— | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Debt to Equity (x) |
0.01x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-99%)
|
0.04x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-94%)
|
— | — |
| Interest Coverage (x) |
-1699.44x
Weak
↓
Weak
Declining
Operating income divided by interest expense
Optimal:
> 5x
|
-76.64x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
-1253.12x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— |
| Net Debt (USD) | $146.00K | $146.00K | — | — |
| Debt / EBITDA (x) |
-0.01x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
-0.02x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $606.68K | $2.17M | $917.72K | — |
| Depreciation Expense (USD) | $381.33K | $341.08K | $239.01K | — |
| Net Income, GAAP (USD) | $-14.32M | $-7.43M | $-6.31M | — |
| Operating Cash Flow (USD) | $-6.22M | $-4.10M | $-2.00M | — |
Secondary lens
Benchmark Lens
Compare SPAI against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare SPAI against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for SPAI
Debt to Equity is in the top quartile (lower is better)
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How SPAI compares to all companies
Peer Comparison
SPAI vs similar peers
Compare SPAI with peers
Stack SPAI against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 4 years · 14 quarters